Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
DISASTERS AVERTED — Near Miss Case Studies
Confusing Insulins Still A Common Mistake
EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners
Rachele Berria on Sanofi Research and New Products
HOMERUN SLIDES — Great Clinical Presentation Highlights
New CGM Categories and Technologies Part 2
CLINICAL GEMS — The Best from Diabetes Texts
A COLLABORATIVE APPROACH TO DIABETES CARE V
APRIL 4-5, 2019 CHARLESTON, SC
A cross continuum of inpatient diabetes care. Hospitals are being incentivized for achieving diabetes care metrics in the patient population in their catchment area which has required them to develop effective healthcare delivery models that impact not only just individual patients but also the patient population as a whole. Hear case studies from Mayo Clinic, MD Anderson, UPMC, Allina Healthcare, Essentia Health and more. Learn about transitioning of care, building and maintaining Inpatient Diabetes Programs and Management, incorporating Triple Aim, diabetes prevention programs, ROI for Tele Diabetes, collaborative diabetes depression models, incorporating SOCIAL DETERMINANTS OF HEALTH measures, financial impact of low literacy on a healthcare system, Cardiovascular risk associated with diabetes and inpatient care, cancer risk associated with diabetes and the inpatient care, managing diabetes in hospitalized patients with chronic Kidney Disease and more. For complete conference details including discounts available for Diabetes In Control Members, click here.
MOST POPULAR ARTICLES OF THE MONTH
#1 Interview: New Drug Cocktail That Increases Human Beta Cell Proliferation at Rapid Rates
#2 HbA1c Variability and Risk of All-Cause Mortality and Cardiovascular Events
#3 ADA’s Position on the Evaluation and Management of Type 2 Diabetes in Youth
Editor's Note
We are often amazed when someone is diagnosed with T1DM when there is no family history. That is because the disease is about 15 times more common in siblings of a patient with diabetes than in the general population. In addition, siblings have an average risk of 6% of developing T1DM.
This week in our Clinical Text, we look at the myriad of testing and genetic research that is going on to try to identify genetic solutions.
Dave Joffe
Editor-in-chief
DISASTERS AVERTED — Near Miss Case Studies
I have a patient who has type 2 diabetes. He was started on long-acting insulin 8 months ago. Before adding the insulin, he was taking a daily GLP-1. He had experienced diabetic ketoacidosis (DKA) while on a SGLT-2, and did not tolerate metformin due to GI side effects. Therefore, these two were no longer options. …
EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners
Rachele Berria MD, PhD is Vice President and Head, Diabetes Medical Unit at Sanofi, Bridgewater, New Jersey. She has a medical degree (undergrad/graduate combined program) and Obstetrics and Gynecology Board Certification from the University of Cagliari School of Medicine, Italy. Her many other educational accomplishments include a Master of Science in Clinical Investigation from the University of Texas Health Science Center at San Antonio, Texas; Ph.D. Degree in Medical Pathophysiology and Pharmacology from the University of Pisa School of Medicine, Italy; a Fellowship in Diabetes and Metabolism from the Internal Medicine Department, University of Texas Health Science Center at San Antonio, Texas; and a Master Practitioner Certification in Effective Communication from the Neurolinguistic Programming Center of New York City, NY.
HOMERUN SLIDES — Great Clinical Presentation Highlights
In this week’s Homerun Slides, the breakdown of the different CGM categories. To download the complete set in PowerPoint format, just use this link: New CGM Categories and Technologies Part 2. Catch up on past Homerun Slides for New CGM Categories and Technologies: New CGM Categories and Technologies Part 1.
CLINICAL GEMS — The Best from Diabetes Texts
Genetic predisposition is an important component of the multifactorial pathogenesis of T1DM. Although often diagnosed in individuals with no known family history of T1DM, the disease is about 15 times more common in siblings of a patient than in the general population. Siblings have an average risk of 6%, although individual risk varies significantly in relation to the extent of sharing predisposing genes with the proband, which allele variants are shared, and other factors. The risk to the offspring of affected mothers and fathers is about 2–3% and 6–7%, respectively. Among twins, the observed disease concordance rates are approximately 8–10% in dizygotic twins and, with extended follow-up, more than 60% in monozygotic twins.
MOST POPULAR ARTICLES OF THE MONTH
Diabetes in Control is pleased to bring you an exclusive interview with Dr. Andrew Stewart. Dr. Stewart and his fellow researchers at the Icahn School of Medicine at Mount Sinai have discovered a novel combination of two classes of drugs that induces the highest rate of proliferation ever observed in adult human beta cells—the cells in the pancreas that produce insulin. The result is an important step toward a diabetes treatment that restores the body’s ability to produce insulin.
Study assesses effect of variable glycemic levels on risk of vascular complication in patients without diabetes.
Specific treatment recommendations outlined for this growing patient population.